Skip to content

iRhythm Holdings, Inc. IRTC Available for sale investments

Available for sale investments at other companies

Baxter International logo
Baxter InternationalBAX
Edwards Lifesciences logo
Edwards LifesciencesEW

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's available for sale investments?
iRhythm Holdings, Inc. (IRTC) reported available for sale investments of $455.24M in Q1 2026.
How has iRhythm Holdings, Inc. 's available for sale investments changed year-over-year?
iRhythm Holdings, Inc. 's available for sale investments increased by 42.1% year-over-year, from $320.26M to $455.24M.
What is the long-term trend for iRhythm Holdings, Inc. 's available for sale investments?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's available for sale investments has grown at a 9.9% compound annual growth rate (CAGR), from $306.41M to $490.17M.